Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
Aspergillosis D001228 5 associated lipids
Blastomycosis D001759 5 associated lipids
Xerostomia D014987 6 associated lipids
Vaginitis D014627 6 associated lipids
Gonorrhea D006069 7 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Otitis Externa D010032 8 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Influenza, Human D007251 11 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
HIV Seropositivity D006679 15 associated lipids
Dermatomycoses D003881 17 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Burns D002056 34 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Kristanc L et al. Effects of the pore-forming agent nystatin on giant phospholipid vesicles. 2012 Biochim. Biophys. Acta pmid:22178865
Adetutu EM et al. Impact of bacterial and fungal processes on 14C-hexadecane mineralisation in weathered hydrocarbon contaminated soil. 2012 Sci. Total Environ. pmid:22154183
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Khan MA et al. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. 2012 FEMS Immunol. Med. Microbiol. pmid:22612788
Martins HP et al. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. 2012 Acta Derm. Venereol. pmid:21918792
Usta Y Persistent hiccups: an unusual presentation and treatment. 2012 J Pain Symptom Manage pmid:22248794
Di Capua R et al. Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology. 2012 Eur. Biophys. J. pmid:22237602
Gerstein AC et al. Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. 2012 Genetics pmid:22714405
Bzik VA et al. Mechanisms of action of zinc on rat intestinal epithelial electrogenic ion secretion: insights into its antidiarrhoeal actions. 2012 J. Pharm. Pharmacol. pmid:22471360
Baugé C et al. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. 2012 Biochim. Biophys. Acta pmid:22425785
Semis R et al. Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. 2012 J. Antimicrob. Chemother. pmid:22499997
Leibovitz E Strategies for the prevention of neonatal candidiasis. 2012 Pediatr Neonatol pmid:22503254
Bhattacharya S et al. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. 2012 Nano Lett. pmid:22375622
Tester R et al. The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. 2012 Benef Microbes pmid:22348910
Jolivot PA et al. [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. 2012 Pathol. Biol. pmid:22361161
Lee MJ et al. Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. 2012 Appl. Microbiol. Biotechnol. pmid:22382166
Pontes HA et al. Oral candidiasis mimicking an oral squamous cell carcinoma: report of a case. 2012 Gerodontology pmid:20633054
Kovac M et al. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. 2012 J Clin Pharm Ther pmid:21332566
Bakhshi M et al. Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. 2012 Gerodontology pmid:22126338
Santos KK et al. Anti-Candida activity of Mentha arvensis and Turnera ulmifolia. 2012 J Med Food pmid:22082100
Ocerin-Guerra I et al. Nystatin-induced acute generalized exanthematous pustulosis. 2012 Actas Dermosifiliogr pmid:23149047
Kumar R et al. A new antifungal coumarin from Clausena excavata. 2012 Fitoterapia pmid:22088496
Castón JJ et al. [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. 2012 Med Clin (Barc) pmid:23103103
Matsubara VH et al. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). 2012 Oral Dis pmid:22059932
Seipke RF et al. Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. 2012 Meth. Enzymol. pmid:23084933
Kaczorowska-Hac B et al. Methemoglobinemia in postchemotherapy stomatitis topical treatment: 2 pediatric cases. 2012 J. Pediatr. Hematol. Oncol. pmid:21900833
Agwu E et al. Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda. 2012 Med. Mycol. pmid:21905950
Bulacio L et al. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. 2012 J Mycol Med pmid:23518170
Yang Y et al. A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. 2012 New Phytol. pmid:21916894
Noss MR and Cha J Erythematous penile lesion. 2012 J Fam Pract pmid:23313994
Giglio M et al. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. 2012 Crit Care pmid:22490643
Xu L et al. Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. 2011 May-Jun Mol Med Rep pmid:21468584
Brito GN et al. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. 2011 Jan-Feb Braz Oral Res pmid:21271179
Berger J et al. Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. 2011 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:21123756
Day TP et al. Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. 2011 Mol. Pharm. pmid:21141891
El-Ridy MS et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. 2011 Drug Dev Ind Pharm pmid:21707323
Zerbib C et al. One-pot synthesis of a new antifungal polymerisable monomer and its characterisation by coordination-ion spray mass spectrometry. 2011 Rapid Commun. Mass Spectrom. pmid:21710593
Huang CY et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. 2011 Mycopathologia pmid:21424606
Mane RS et al. Synthesis of an adenine nucleoside containing the (8'R) epimeric carbohydrate core of amipurimycin and its biological study. 2011 J. Org. Chem. pmid:21381774
Woods O and Saliba I Effect of nystatin on Guinea Pigs' inner ear. 2011 Neurotox Res pmid:21384237
Kodedová M et al. Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. 2011 BioTechniques pmid:21231924
Stewart AK et al. Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. 2011 Am. J. Physiol., Cell Physiol. pmid:21209359
Orce G et al. β-Cyclodextrin and permeability to water in the bladder of Bufo arenarum. 2011 Can. J. Physiol. Pharmacol. pmid:21609275
Messier C and Grenier D Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. 2011 Mycoses pmid:21615543
Acar A et al. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. 2011 Burns pmid:21354707
Mayercik VA et al. Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. 2011 Arch. Ophthalmol. pmid:21746988
Pendela M et al. Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. 2011 J Pharm Biomed Anal pmid:21794999
Yamasaki M et al. Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro. 2011 J. Parasitol. pmid:21756054
Valitova JN et al. Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. 2011 Phytochemistry pmid:21726881
Ebert S et al. Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. 2011 Z Gerontol Geriatr pmid:21732154